Effect of Bamlanivimab as Monotherapy or in Combination with Etesevimab or Sotrovimab on Persistently High Viral Load in Patients with Mild-to-Moderate COVID-19: A Randomized, Phase 2 BLAZE-4 Trial.
Russell M NicholsLisa MacphersonDipak R PatelWendy W YehAmanda PeppercornPublished in: Infectious diseases and therapy (2024)
ClinicalTrials.gov identifier, NCT04634409.